You are here

Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo Nordisk, Evotec partner in metabolic disease drug discovery pact

BioPharma Dive

Tue, 09/26/23 - 09:51 pm

Tags:

Novo Nordisk, Evotec, drug discovery, LAB eN², metabolic diseases

Novo Nordisk and Valo to research cardiometabolic treatments

Reuters

Mon, 09/25/23 - 10:16 am

Tags:

Novo Nordisk, Valo Health, R&D, artificial intelligence, cardiometabolic diseases

Obesity Drug Market Set to Hit $100 Billion by 2035, BMO Says

Yahoo/Bloomberg

Sun, 09/24/23 - 08:56 pm

Tags:

Novo Nordisk, Ozempic, Wegovy, obesity, weight loss

Why a hidden message in Ozempic’s logo represents a big shift in drug branding

Fast Company

Fri, 09/22/23 - 12:03 pm

Tags:

Novo Nordisk, Ozempic, logo, branding, diabetes, weight loss

Novo Nordisk Foundation to establish €127 million cell therapy plant

Biopharma Reporter

Thu, 09/21/23 - 06:39 pm

Tags:

Novo Nordisk, cell therapy, Denmark

Why Novo Nordisk Stock Edged Higher Today

Motley Fool

Wed, 09/20/23 - 11:06 pm

Tags:

Novo Nordisk, Ypsomed, drug manufacturing

Inside the FDA's Form 483 findings at Novo Nordisk's North Carolina semaglutide plant

Fierce Pharma

Tue, 09/19/23 - 10:19 pm

Tags:

Novo Nordisk, FDA, drug manufacturing, semaglutide, North Carolina

Novo Nordisk taps Aspen to help produce insulin for Africa

Fierce Pharma

Tue, 09/19/23 - 10:49 am

Tags:

Novo Nordisk, diabetes, Africa, insulin, Aspen Pharmacare, drug manufacturing

Novo Nordisk Dives After FDA Reportedly Finds 'Objectionable' Conditions At A Key Wegovy Plant

Investors Business Daily

Mon, 09/18/23 - 07:58 pm

Tags:

Novo Nordisk, drug manufacturing, FDA, Wegovy

Novo Nordisk hires private U.S. firm to handle some Wegovy pen assembly

Reuters

Mon, 09/18/23 - 12:35 pm

Tags:

Novo Nordisk, Wegovy, PCI Pharma Services, drug manufacturing

Ozempic-Maker Invests in Renewables

Daily Upside

Thu, 09/14/23 - 11:06 pm

Tags:

Novo Nordisk, sustainability, renewable energy

Novo, Lilly set to dominate $71B GLP-1 drug market by 2032: J.P. Morgan

Fierce Pharma

Mon, 09/11/23 - 12:05 pm

Tags:

Novo Nordisk, Eli Lilly, GLP-1 agonist, obesity

After treatment with semaglutide, people with newly diagnosed type 1 diabetes needed little or no insulin

Medical News Today

Sun, 09/10/23 - 08:03 pm

Tags:

Novo Nordisk, Ozempic, semaglutide, type 1 diabetes

Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts

Fierce Pharma

Fri, 09/8/23 - 10:29 am

Tags:

M&A, patent cliffs, Merck, JNJ, Pfizer, GSK, Novartis, Eli Lilly, Novo Nordisk

Novo Nordisk Is Already Working on Ozempic 2.0

Motley Fool

Thu, 09/7/23 - 10:12 am

Tags:

Novo Nordisk, diabetes, obesity, weight loss, Ozempic, Wegovy

The 10 highest value R&D projects in biopharma

Fierce Biotech

Wed, 09/6/23 - 10:17 am

Weight-loss drug maker Novo Nordisk becomes Europe’s most valuable company

FT.com

Tue, 09/5/23 - 11:38 am

Tags:

Novo Nordisk, Wegovy, Europe, weight loss

Novo Nordisk launches Wegovy for obese patients in UK

Pharmaceutical Business Review

Tue, 09/5/23 - 11:25 am

Tags:

Novo Nordisk, UK, Wegovy, obesity

Signal: Novo Nordisk market cap higher than Danish GDP due to obesity drugs

Clinical Trials Arena

Fri, 09/1/23 - 12:18 pm

Tags:

Novo Nordisk, Wegovy, Ozempic, Denmark

Wegovy costs $1.1m to prevent one heart attack, stroke, or cardiovascular death

Airfinity

Thu, 08/31/23 - 11:52 am

Tags:

Novo Nordisk, Wegovy, Ozempic, cardiovascular disease

Pages

last 30 twitter posts